Vanquis Banking Group Valuation
Is VANQL undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
5/6Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of VANQL when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: VANQL (£0.45) is trading below our estimate of fair value (£2.36)
Significantly Below Fair Value: VANQL is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for VANQL?
Key metric: As VANQL is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
What is VANQL's PS Ratio? | |
---|---|
PS Ratio | 0.4x |
Sales | UK£319.90m |
Market Cap | UK£114.83m |
Key Statistics | |
---|---|
Enterprise Value/Revenue | n/a |
Enterprise Value/EBITDA | n/a |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does VANQL's PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 1.1x | ||
SUS S&U | 2.6x | 20.5% | UK£170.1m |
ASAI ASA International Group | 0.5x | 10.2% | UK£63.8m |
HAT H&T Group | 0.7x | 7.9% | UK£153.5m |
RFX Ramsdens Holdings | 0.8x | 5.5% | UK£71.8m |
VANQL Vanquis Banking Group | 0.3x | 13.5% | UK£103.6m |
Price-To-Sales vs Peers: VANQL is good value based on its Price-To-Sales Ratio (0.4x) compared to the peer average (1.1x).
Price to Sales Ratio vs Industry
How does VANQL's PS Ratio compare vs other companies in the European Consumer Finance Industry?
Price-To-Sales vs Industry: VANQL is good value based on its Price-To-Sales Ratio (0.4x) compared to the European Consumer Finance industry average (1.6x).
Price to Sales Ratio vs Fair Ratio
What is VANQL's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 0.4x |
Fair PS Ratio | 0.9x |
Price-To-Sales vs Fair Ratio: VANQL is good value based on its Price-To-Sales Ratio (0.4x) compared to the estimated Fair Price-To-Sales Ratio (0.9x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | UK£0.45 | UK£0.85 +91.6% | 19.5% | UK£1.10 | UK£0.66 | n/a | 4 |
Nov ’25 | UK£0.44 | UK£0.85 +93.8% | 19.5% | UK£1.10 | UK£0.66 | n/a | 4 |
Oct ’25 | UK£0.58 | UK£0.92 +57.9% | 22.1% | UK£1.20 | UK£0.66 | n/a | 5 |
Sep ’25 | UK£0.57 | UK£0.94 +65.6% | 21.8% | UK£1.20 | UK£0.66 | n/a | 5 |
Aug ’25 | UK£0.57 | UK£0.96 +69.7% | 23.3% | UK£1.20 | UK£0.66 | n/a | 5 |
Jul ’25 | UK£0.49 | UK£0.94 +91.3% | 22.1% | UK£1.20 | UK£0.66 | n/a | 6 |
Jun ’25 | UK£0.55 | UK£0.88 +60.9% | 28.2% | UK£1.20 | UK£0.50 | n/a | 7 |
May ’25 | UK£0.47 | UK£1.10 +132.5% | 29.5% | UK£1.63 | UK£0.50 | n/a | 8 |
Apr ’25 | UK£0.53 | UK£1.22 +128.9% | 30.6% | UK£1.80 | UK£0.60 | n/a | 8 |
Mar ’25 | UK£1.23 | UK£1.90 +54.6% | 55.7% | UK£4.38 | UK£1.03 | n/a | 7 |
Feb ’25 | UK£1.18 | UK£1.90 +60.8% | 55.7% | UK£4.38 | UK£1.03 | n/a | 7 |
Jan ’25 | UK£1.30 | UK£1.81 +38.9% | 49.5% | UK£4.06 | UK£1.03 | n/a | 8 |
Dec ’24 | UK£1.11 | UK£1.81 +62.4% | 49.5% | UK£4.06 | UK£1.03 | n/a | 8 |
Nov ’24 | UK£1.16 | UK£2.42 +108.9% | 47.7% | UK£4.20 | UK£1.03 | UK£0.44 | 8 |
Oct ’24 | UK£1.27 | UK£2.95 +133.0% | 40.0% | UK£4.50 | UK£1.15 | UK£0.58 | 8 |
Sep ’24 | UK£1.06 | UK£2.95 +177.8% | 40.0% | UK£4.50 | UK£1.15 | UK£0.57 | 8 |
Aug ’24 | UK£1.28 | UK£3.19 +150.2% | 29.2% | UK£4.50 | UK£1.90 | UK£0.57 | 7 |
Jul ’24 | UK£1.91 | UK£3.69 +93.5% | 37.7% | UK£6.58 | UK£1.90 | UK£0.49 | 8 |
Jun ’24 | UK£2.18 | UK£3.69 +69.2% | 37.5% | UK£6.55 | UK£1.90 | UK£0.55 | 8 |
May ’24 | UK£2.25 | UK£3.69 +64.3% | 37.5% | UK£6.55 | UK£1.90 | UK£0.47 | 8 |
Apr ’24 | UK£2.38 | UK£3.65 +53.1% | 37.2% | UK£6.55 | UK£1.45 | UK£0.53 | 8 |
Mar ’24 | UK£2.24 | UK£3.58 +60.0% | 38.0% | UK£6.55 | UK£1.45 | UK£1.23 | 8 |
Feb ’24 | UK£2.38 | UK£3.69 +55.0% | 36.4% | UK£6.55 | UK£1.45 | UK£1.18 | 8 |
Jan ’24 | UK£1.94 | UK£3.69 +90.6% | 36.3% | UK£6.55 | UK£1.45 | UK£1.30 | 8 |
Dec ’23 | UK£1.96 | UK£3.69 +88.4% | 36.3% | UK£6.55 | UK£1.45 | UK£1.11 | 8 |
Nov ’23 | UK£1.72 | UK£3.58 +108.6% | 32.0% | UK£6.04 | UK£1.45 | UK£1.16 | 9 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.
Discover undervalued companies
BFF Bank
€1.6b
Provides financial services to suppliers of the national health system and public administration sector in Italy, Croatia, the Czech Republic, France, Greece, Poland, Portugal, the Slovak Republic, and Spain.
0RON
€8.83
7D
-0.8%
1Y
-15.4%
ASA International Group
UK£64.3m
Provides microfinancing services in Africa and Asia.
ASAI
UK£0.64
7D
-0.8%
1Y
24.8%
Man Group
UK£2.4b
Man Group Limited is a publicly owned investment manager.
EMGL
UK£2.08
7D
1.1%
1Y
-2.8%